Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

CertaraJuly 20, 2026

Conference

EANM 2026

–

Danielle PillsburyJuly 20, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Webinar

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Jan ChristophersonJuly 14, 2026

Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

CertaraJuly 13, 2026

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

CertaraJuly 13, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

CertaraJuly 9, 2026

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhDJuly 7, 2026

On-Demand Webinar

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…

CertaraJuly 1, 2026

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

CertaraJune 26, 2026

Drug Development

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

EANM 2026

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Enhancing clinical trials with real-world evidence in pregnancy research

Newsletter sign up

Quick links

Solutions

Contact